SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Teva Pharmaceuticals
TEVA 20.25+1.1%9:53 AM EDT

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: Lance Bredvold12/6/2022 12:31:47 PM
1 Recommendation

Recommended By
RonBerk

  Read Replies (1) of 340
 
Thinking a bit more about the legal problem TEVA faces with opioid settlements. I am aware that juries will always give enough away to bankrupt the golden goose. And there will always be one more litigant who will risk getting nothing to get just a bit more of a benefit. Or who decide to enter a lawsuit later than most. Thus, it is in the TEVA;s interest to have litigants solve the problem of getting the maximum amount possible while still leaving the company able to survive and pay it. They can't demand all the money be put into escrow as TEVA doesn't have that much at the time of agreement.
My conclusion is that we want all challenges settled in a fell swoop with no hanger ons trying for another buck. And whether it's possible for an agreement which places a set amount into an endowment over which all the remaining claimants can fight for a limited pot is possible or a spunout company which takes on all the new claims but has a limited ability to generate more cash flow while leaving the rest of TEVA functioning in it's traditional role--I don't know.
For me then, I don't want to own more TEVA until I'm pretty sure they have all the challenges behind them and then I can see a huge recovery as EPS becomes predictable and the low PE expands to more normal size.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext